RecruitingNCT07093528
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
CMR Substudy of Coronary Sinus Reducer for the Management of Symptomatic Heart Failure With a Preserved Ejection Fraction (HFpEF) Associated With Coronary Microvascular Dysfunction (CMD)
Sponsor
Mayo Clinic
Enrollment
25 participants
Start Date
Oct 16, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Age ≥18
- Enrollment in main CS-reducer HFPEF study IRB# 25-002292
Exclusion Criteria2
- Metal implants that are not suitable for MRI
- Inability or unwillingness of individual to give written informed consent.
Interventions
DIAGNOSTIC_TESTCardiovascular Magnetic Resonance (CMR)
Patients will consent to undergo a 50-minute non-invasive stress perfusion CMR.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07093528
Related Trials
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
NCT042377011 location
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459564 locations
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
NCT049457071 location
Transitions of Care Clinic (TOCC)
NCT069378271 location
Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
NCT074017711 location